Admedus is a medical technologies company delivering
clinically superior solutions to help healthcare professionals to
create life-changing outcomes for patients.

Our Technology

Our proprietary ADAPT engineering process
produces implantable tissue bio-scaffolds for a range of cardiovascular and vascular applications.


Clinically superior solutions that last a lifetime


Admedus CEO talks quarterly results with Proactive Investors
Our CEO Wayne Paterson spoke to Proactive Investors Andrew Scott following the release of our quarterly update for the period
Read more.
Future takes shape with US launch of CardioCel 3D
Today marks a significant milestone for Admedus Limited (ASX:AHZ), and our ADAPT® technology, with the official launch in North America
Read more.